10 Moderna operations leaders

Experience: Site Head, VP Norwood Drug Substance Operations · Moderna

Site Head, VP Norwood Drug Substance Operations at Moderna since November 2025. As Head of Global Drug Substance Process and Laboratory Strategy at Moderna (2025), she led global strategy and execution for the Drug Substance network and lab integration, including long-range planning and alignment across sites. She was also Executive Director, Head of Quality at Moderna (2023–2025).

Experience: Executive Director - Site Head · Moderna

Executive Director - Site Head at Moderna since November 2025, a role her profile headline ties to Moderna's INT site. She writes that as Head of Operations at Moderna's Marlborough INT facility she led its operational startup, beginning from construction. Her other Moderna roles include Sr. Director, INT Commercial Ops Readiness Lead (2023–2025) and Sr. Director, Engineering Projects - Clinical Manufacturing (2022–2023).

Experience: INT Site Head, Executive Director of Operations · Moderna

INT Site Head, Executive Director of Operations at Moderna since January 2023. At Adverum Biotechnologies she was Executive Director, Manufacturing and Operations, Site Head (2021) and Vice President, Tech Ops Executive Director, Tech Development (2021–2022). Her profile says she has built and scaled operations across mRNA, gene therapy and monoclonal antibodies.

Experience: Senior Director of Operations · Moderna

Senior Director of Operations at Moderna since October 2025. His other Moderna roles include Director, Research and Early Development Operations (2023–2025) and Associate Director, Research & Early Development Operations (2022–2023). He has also been Secretary, Board of Directors at LabOps Unite Community since 2023.

Experience: VP, Norwood Drug Substance Site Head · Moderna

Former VP, Norwood Drug Substance Site Head at Moderna (2024–2025) and Executive Director, DS Operations there (2022–2024); he has been Head, INT Manufacturing at Moderna since November 2025. He was Senior Director, Single Use Facility Manufacturing at Bristol Myers Squibb (2021–2022), and his profile describes leading technical, investigation and continuous improvement teams for biologics drug substance manufacturing.

Experience: Chief Technical Operations and Quality Officer · Moderna

Chief Technical Operations and Quality Officer at Moderna since October 2022; his profile headline also lists him as an Executive Committee Member at Moderna. At Novartis he was Chief Culture Officer (2020–2022), Global People & Organization Transformation Lead (2019–2020) and Head of Global Chemical Operations and Anti-Infectives (2017–2019).

Experience: VP, Drug Product Operations · Moderna

VP, Drug Product Operations at Moderna since June 2023. Her other roles include Vice President Global Quality for Biologic & Sterile Ops at Bristol Myers Squibb (2020–2023), Head of Quality, Latin America & Puerto Rico at Teva Pharmaceuticals (2018–2020) and Executive Director Quality at Novartis (2012–2018).

Experience: Senior Vice President Manufacturing and Site Head MITC · Moderna

Former Senior Vice President Manufacturing and Site Head MITC at Moderna (2024–2025), a role his profile places in Harwell, England. His other Moderna roles were Senior Vice President International Resilience Manufacturing (2023–2024), Senior Vice President International Manufacturing (2020–2023) and Senior Vice President Manufacturing and Site Head Norwood (2019–2020). He was General Director (Site Head) of Novartis Technical Operations Solids Site Spain (2015–2019).

Experience: SVP, Global Drug Substance Operations · Moderna

SVP, Global Drug Substance Operations at Moderna since May 2023. His other roles include SVP, Chief Technical Officer at Alvotech (2020–2023) and, at Novartis, VP, Manufacturing Operations & Site Head (2018–2020) and Site Head, Drug Substance Bioproduction Basel (2017–2018). His profile cites experience across small molecules, biologics, gene therapies and mRNA vaccines.

Experience: SVP Drug Product Operations and Global Head of MS&T AS&T · Moderna

SVP Drug Product Operations and Global Head of MS&T AS&T at Moderna since July 2025. Her other Moderna roles include SVP Global Drug Product Operations (2023–2025) and Senior Vice President North America Operations (2022–2023). At Amgen she was Vice President Drug Substance Operations (2021–2022) and Executive Director, Drug Substance Plant Manager (2019–2021).